Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects
Anu Haveri, Anna Solastie, Nina Ekström, et al.
European Journal of Immunology (2022) Vol. 52, Iss. 5, pp. 816-824
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
Lok Bahadur Shrestha, Charles S. P. Foster, William D. Rawlinson, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 406
Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas
Paul Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 4, pp. 642-652
Open Access | Times Cited: 201
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
Fanglei Zuo, Hassan Abolhassani, Likun Du, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 136
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality
Min Kyung Jung, Seong Dong Jeong, Ji Yun Noh, et al.
Nature Microbiology (2022) Vol. 7, Iss. 6, pp. 909-917
Open Access | Times Cited: 54
Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
Aleksandr V. Kudriavtsev, Anna Vakhrusheva, Valery Novoseletsky, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1603-1603
Open Access | Times Cited: 46
Protective role of SARS-CoV-2 anti-S IgG against breakthrough infections among European healthcare workers during pre and post-Omicron surge—ORCHESTRA project
Gianluca Spiteri, Marika D’Agostini, Mahsa Abedini, et al.
Infection (2024) Vol. 52, Iss. 4, pp. 1347-1356
Open Access | Times Cited: 8
Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection
Endeshaw Chekol Abebe, Markeshaw Tiruneh G Medhin, Awgichew Behaile T Mariam, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 1871-1887
Open Access | Times Cited: 30
Neutralizing potency of COVID‐19 vaccines against the SARS‐CoV‐2 Omicron (B.1.1.529) variant
Giuseppe Lippi, Camilla Mattiuzzi, Brandon Michael Henry
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1799-1802
Open Access | Times Cited: 27
Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: A systematic review
Yuxuan Du, Long Chen, Yuan Shi
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 25
T‐cell responses to SARS‐CoV‐2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine
Yongzheng Li, Xiuwen Wang, Junyan Jin, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 8, pp. 3998-4004
Open Access | Times Cited: 24
A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens
Shobha Upreti, Mukesh Samant
Pharmaceutical Research (2022) Vol. 39, Iss. 9, pp. 2119-2134
Open Access | Times Cited: 24
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study
Timothée Bruel, Laurie Pinaud, Laura Tondeur, et al.
EClinicalMedicine (2022) Vol. 51, pp. 101576-101576
Open Access | Times Cited: 23
Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort
Masae Itamochi, Shunsuke Yazawa, Noriko Inasaki, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2234-2242
Open Access | Times Cited: 14
Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19
Nina Ekström, Tuija M. Leino, Aapo Juutinen, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 247-247
Open Access | Times Cited: 3
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding
Gemma E. Hartley, Holly A. Fryer, Paul A. Gill, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens
Jerôme D.G. Comes, Kristel Doets, Thijmen Zegers, et al.
Vaccine (2024) Vol. 42, Iss. 11, pp. 2895-2908
Open Access | Times Cited: 2
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Sabina Zurac, Cristian Vlădan, Octavian Dincă, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines
Shaojun Liu, Joseph GS Tsun, Genevieve P. G. Fung, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Third dose COVID-19 mRNA vaccine enhances IgG4 isotype switching and recognition of Omicron subvariants by memory B cells after mRNA but not adenovirus priming
Gemma E. Hartley, Holly A. Fryer, Paul A. Gill, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
David J. Sullivan, Massimo Franchini, Michael J. Joyner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15
Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
Alexander Kudryavtsev, Anna Vakhrusheva, Valery Novoseletsky, et al.
(2022)
Open Access | Times Cited: 10
Immunogenicity and risk of disease flare after a three-dose regimen with SARS-CoV-2 vaccination in patients with systemic lupus erythematosus: results from the prospective cohort study COVAC-SLE
Emilie Stavnsbjerg Larsen, Anna Christine Nilsson, Sören Möller, et al.
Clinical and Experimental Rheumatology (2022)
Open Access | Times Cited: 9
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Gang Wang, Abhishek Kumar Verma, Juan Shi, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection
Nina Ekström, Anu Haveri, Anna Solastie, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 12
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top